Extracorporeal Lung Support for Hypercapnic Ventilatory Failure
Authors:
- 1 September 2018
- journal article
- research article
- Published by SAGE Publications in Respiratory Care
- Vol. 63 (9) , 1174-1179
Abstract
Extracorporeal lung support can be achieved using extracorporeal membrane oxygenation (ECMO) and extracorporeal CO 2 removal. The ECMO systems allow a total lung support, providing both blood oxygenation and CO 2 removal. Unlike ECMO, extracorporeal CO 2 removal refers to an extracorporeal circuit that provides a partial lung support and selectively extracts CO 2 from blood. The concept of partial extracorporeal lung support by removing only CO 2 without effect on oxygenation was first proposed in 1977 by Kolobow and Gattinoni, with the aim to reduce breathing frequency, ventilator tidal volumes, and inspiratory pressures, facilitating lung-protective ventilation. Patients with end-stage chronic lung disease can survive, while waiting for lung transplantation, only if treated with mechanical ventilation or extracorporeal lung support. ECMO has been considered a suitable approach as a bridge to lung transplantation for patients with advanced respiratory failure waiting for lung transplantation. Extracorporeal CO 2 removal has been proposed for the treatment of COPD patients suffering from exacerbation to avoid invasive mechanical ventilation. The rationale is to combine the improvement of alveolar ventilation by using noninvasive ventilation with muscle unload provided by removing CO 2 directly from the blood, using an extracorporeal device. Increasing attention has been given to the possibility of patients performing a variety of physical activities while receiving extracorporeal lung support. This is possible thanks to the continuous development of technology together with the customization of sedative protocols. Awake extracorporeal support is a specific approach in which the patient is awake and potentially cooperative while receiving ECMO. The present analysis aims to synthesize the main results obtained by using extracorporeal circuits in patients with respiratory failure, particularly in those patients with hypercapnia.Keywords
This publication has 27 references indexed in Scilit:
- Extracorporeal Co2 Removal in Hypercapnic Patients At Risk of Noninvasive Ventilation FailureCritical Care Medicine, 2015
- Pilot Study of Extracorporeal Carbon Dioxide Removal to Facilitate Extubation and Ambulation in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of the American Thoracic Society, 2013
- A Novel Extracorporeal CO2 Removal SystemChest, 2013
- Extracorporeal Membrane Oxygenation in Awake Patients as Bridge to Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Rescue Therapy With a Pumpless Extracorporeal Lung Assist Device in a Patient With Acute Interstitial Lung Disease and Severe Refractory HypercapniaRespiratory Care, 2012
- Outcomes of Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the United States, 1998–2008American Journal of Respiratory and Critical Care Medicine, 2012
- Successful treatment of severe asthma-associated plastic bronchitis with extracorporeal membrane oxygenationJournal of Anesthesia, 2011
- Non-invasive ventilation in acute respiratory failureThe Lancet, 2009
- Blood acidification enhances carbon dioxide removal of membrane lung: an experimental studyIntensive Care Medicine, 2009
- Near-fatal asthma: recognition and managementCurrent Opinion in Pulmonary Medicine, 2008